Neuraxial Versus Systemic Analgesia for Latent Phase Labor Effect on Rate of Operative Delivery

Pregnancy Clinical Trial

Official title:

Early Compared With Late Neuraxial Analgesia in Nulliparous Labor Induction

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00380978
• Other study ID #: 0524-009
• Status: Completed
• Phase: N/A
• First received: September 25, 2006
• Last updated: March 17, 2014
• Start date: October 2001
• Est. completion date: September 2008

Study information

• Verified date: March 2014
• Source: Northwestern University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Institutional Review Board
• Study type: Interventional

Clinical Trial Summary

The purpose of this study in nulliparous women undergoing induction of labor is to determine whether initiation of neuraxial analgesia compared to systemic opioid analgesia early in labor (< 4 cm cervical dilation)affects the cesarean delivery rate.

Description:

Women in early labor frequently request pain medication. Obstetricians may prescribe narcotics (administered as an intravenous (IV) or intramuscular (IM) injection). However, IV or IM narcotics provide incomplete pain relief and have maternal and fetal/neonatal side effects, e.g., maternal drowsiness, respiratory depression, nausea, vomiting, and neonatal respiratory depression. Other obstetricians allow their patients to request early neuraxial (spinal or epidural) analgesia. The results of several studies comparing patients who received epidural versus IV/IM narcotic labor analgesia (not specifically in early labor)suggest that initiation of early neuraxial analgesia may be associated with higher Cesarean delivery rates. It has been hypothesized that epidural/spinal local anesthetics may induce pelvic musculature relaxation leading to failure of fetal descent and rotation. However, early pain may be a marker for other factors that increase the risk of Cesarean delivery, e.g., large or malpositioned baby, or dysfunctional labor. Whether or not early neuraxial analgesia (particularly if narcotic based, which would not cause pelvic muscle paralysis) compared to IV/IM narcotics, adversely affects the outcome of labor has not been studied in a randomized, prospective fashion. The purpose of this study is to compare Cesarean and forcep delivery rates, and quality of pain relief, in first-time mothers undergoing induction of labor who receive neuraxial versus IV/IM analgesia for early labor (cervical dilation < 4 cm).

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1026
• Est. completion date: September 2008
• Est. primary completion date: September 2008
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• induction of labor

• nulliparity

• >36 weeks gestation

• singleton

• vertex position

• cervical dilation < 4 cm at first request for analgesia

• desires neuraxial analgesia

Exclusion Criteria:

• spontaneously laboring

• multiparity

• nonvertex presentation

• at or >4cm at analgesia request

• chronic opioid therapy

• acute opioid therapy within 4 hours of analgesia request

• allergy to study drugs (hydromorphone, fentanyl, bupivacaine, lidocaine)

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

• Labor Pain
• Pregnancy

Intervention

Procedure:
• combined spinal epidural analgesia
Analgesia was initiated in the early group using a standard needle-through-needle technique with intrathecal fentanyl 25 mcg and an epidural test dose of lidocaine 15 mg/ml and epinephrine 5 mcg/ml in 3ml. At the second analgesia request, the cervix was examined. Epidural analgesia was initiated with a dilute bupivicaine/fentanyl solution if the cervix was less than 4 cm. If the cervix was 4 cm or more, epidural analgesia was initiated with bupivicaine 1.25 mg/ml. If no cervical exam was performed at the second request for analgesia, the cervix was assumed to be at least 4 cm dilated. Thereafter, analgesia was maintained in all participants in the early group with patient-controlled epidural analgesia.
• late analgesia (systemic)
Analgesia was initiated in the late group with hydromorphone 1mg intramuscularly (IM) and 1 mg intravenously (IV). If the cervix was less than 4 cm at the second analgesia request, hydromorphone analgesia was repeated. Epidural analgesia was initiated with bupivicaine 1.25 mg/ml if the cervix was 4 cm or more. At the third analgesia request, epidural analgesia was initiated regardless of cervical dilation. Thereafter, epidural analgesia was maintained with patient controlled analgesia until delivery.

Locations

Country	Name	City	State
United States	Northwestern Memorial Hospital	Chicago	Illinois

Sponsors (2)

Lead Sponsor	Collaborator
Northwestern University	International Anesthesia Research Society (IARS)

Country where clinical trial is conducted

United States, 

References & Publications (1)

Wong CA, Scavone BM, Peaceman AM, McCarthy RJ, Sullivan JT, Diaz NT, Yaghmour E, Marcus RJ, Sherwani SS, Sproviero MT, Yilmaz M, Patel R, Robles C, Grouper S. The risk of cesarean delivery with neuraxial analgesia given early versus late in labor. N Engl J Med. 2005 Feb 17;352(7):655-65. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Delivered by Cesarean Section	The decision to proceed to operative delivery was made by the obstetric team for maternal or fetal indications.	Time form initiation of labor analgesia to delivery (up to 24 hours)	No
Secondary	Instrumented Vaginal Delivery	The decision to proceed to assisted/instrumental delivery was made by the obstetric team for maternal or fetal indications.	At time of decision for delivery	No
Secondary	Duration of Labor	Labor was induced by initiating an oxytocin infusion or by infusing extra-amniotic saline followed by oxytocin. All participants had continuous external electronic fetal heart rate (FHR) monitoring and tocodynamometry. Internal fetal scalp electrodes were placed when the external tracing was not interpretable, and intrauterine pressure catheters were used to measure the intensity of contractions when deemed necessary by the obstetricians. Artificial rupture of membranes was performed, and nurses titrated oxytocin infusions according to institutional protocol.	Initiation of induction of labor to time of delivery	No
Secondary	Indication for Cesarean Delivery	The decision to proceed to operative delivery was made by the obstetric team for maternal or fetal indications.	At time of decision for delivery	No
Secondary	Analgesia Efficacy	Patients were asked to rate their average pain score using an 11-point verbal rating score (VRS)for pain (0 - 10: 0= no pain, 10= worst pain imaginable) between 1st and 2nd analgesia request.	At first and second analgesia requests	No
Secondary	Nausea	Participants were asked to rate their nausea (as none, mild, moderate, or severe) and report the presence or absence of vomiting.	At second analgesia request	No
Secondary	Neonatal Outcome (APGAR Score < 7 at 5 Minutes)	Infant's Apgar scores measured at 5 minutes of life and were assigned by nurses and pediatricians responsible for neonatal assessment. The Apgar score is determined by evaluating the newborn baby on five simple criteria on a scale from zero to two, then summing the five values. The categories are skin color, pulse, reflex to stimulation, muscle tome, and breathing. The test was done at one and five minutes after birth, and may be repeated later if the score is and remains low. Scores 3 and below are generally regarded as critically low, 4 to 6 fairly low, and 7 to 10 generally normal.	APGAR score at 5 minutes	No
Secondary	Vomiting	Vomiting during labor analgesia	Vomiting at second analgesia request	No